New shot could tame stubborn high cholesterol

NCT ID NCT07421297

Recruiting now Disease control Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Feb 20, 2026 · Last updated May 09, 2026 · Updated 17 times

Summary

This study tests a new medicine called SYH2053, given as a shot under the skin, to see if it safely lowers 'bad' LDL cholesterol in people with high cholesterol or mixed lipid problems. About 760 adults whose cholesterol is not at goal will receive either the drug or a placebo. The main goal is to measure the drop in LDL cholesterol over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-FAMILIAL HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Affiliation: Peking University Third Hospital
NOT_YET_RECRUITING

Beijing, Beijing Municipality, China
Affiliation: Peking University Third Hospital
RECRUITING

Beijing, Beijing Municipality, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

NON-FAMILIAL HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA